Search Results for "Alterna Cigs Free Trial"

06:19 EDT 28th April 2015 | BioPortfolio

Matching Channels

Free perforation

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Vitamin E Toxicity

Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and ...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Matching News

Survey: E-cigs surpass regular cigs in teen use

Schools Start Treating E-Cigs as Drug Paraphernalia

Read more about Schools Start Treating E-Cigs as Drug Paraphernalia

Survey: E-Cigs Surpass Regular Cigarettes in Teen Use

WASHINGTON (AP) — Electronic cigarettes have surpassed traditional smoking in popularity among teens, the government's annual drug use survey finds.Even as tobacco smoking by teens dropped to new lo...

Novel Polymer and Carrier-Free Drug-Coated Stent Trial Completes Enrollment

Biosensors International has announced completion of patient enrollment in LEADERS Free Japan, a ground-breaking trial involving BioFreedom, the company’s novel polymer and carrier-free drug-coated ...

Teens Take Up E-Cigs Instead of Smoking

(MedPage Today) -- Overall tobacco use among adolescents rose in 2014 over the previous year.

E-Cigarettes May Be Less Addictive

Brett Smith for - Your Universe Online While e-cigarette vendors seem to be everywhere these days, the jury is still out on whether or not they are a safer alternative to tobacco product...

Moberg Pharma changes in Board of Directors

Moberg Pharma AB announces that George E. Aitken-Davies has resigned from the Board of Directors of Moberg Pharma in conjunction with the final earn-out payment related to the acquisition of Alterna L...

Viewpoints: Seniors’ Fears Of Obamacare; Kochs Lose Mont. Medicaid Fight; Regulate E-Cigs

A selection of opinions on health care from around the country.

Matching PubMed Articles

A study on the optics of copper indium gallium (di)selenide (CIGS) solar cells with ultra-thin absorber layers.

We present a systematic study of the effect of variation of the zinc oxide (ZnO) and copper indium gallium (di)selenide (CIGS) layer thickness on the absorption characteristics of CIGS solar cells usi...

Effectiveness of the Electronic Cigarette: An Eight-Week Flemish Study with Six-Month Follow-up on Smoking Reduction, Craving and Experienced Benefits and Complaints.

Smoking reduction remains a pivotal issue in public health policy, but quit rates obtained with traditional quit-smoking therapies remain disappointingly low. Tobacco Harm Reduction (THR), aiming at l...

Suppressing lossy-film-induced angular mismatches between reflectance and transmittance extrema: optimum optical designs of interlayers and AR coating for maximum transmittance into active layers of CIGS solar cells.

The investigation of optimum optical designs of interlayers and antireflection (AR) coating for achieving maximum average transmittance (Tave) into the CuIn1-xGaxSe2 (CIGS) absorber of a typical CIGS ...

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studi...

Progression-free survival as an end-point in solid tumours - Perspectives from clinical trials and clinical practice.

Progression-free survival (PFS) is an end-point in an increasing number of cancer clinical trials, informing both regulatory bodies and clinical practice. PFS is utilised both as a surrogate end-point...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement